A detailed history of Congress Asset Management CO transactions in Repligen Corp stock. As of the latest transaction made, Congress Asset Management CO holds 103,764 shares of RGEN stock, worth $14.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
103,764
Previous 93,922 10.48%
Holding current value
$14.9 Million
Previous $11.8 Million 30.43%
% of portfolio
0.11%
Previous 0.09%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$119.79 - $167.35 $1.18 Million - $1.65 Million
9,842 Added 10.48%
103,764 $15.4 Million
Q2 2024

Aug 02, 2024

BUY
$120.0 - $182.95 $709,080 - $1.08 Million
5,909 Added 6.71%
93,922 $11.8 Million
Q1 2024

Apr 11, 2024

BUY
$170.78 - $208.42 $1.91 Million - $2.34 Million
11,213 Added 14.6%
88,013 $16.2 Million
Q4 2023

Mar 04, 2024

BUY
$114.17 - $185.35 $6.04 Million - $9.8 Million
52,868 Added 220.91%
76,800 $13.8 Million
Q3 2023

Nov 01, 2023

BUY
$138.78 - $176.51 $680,022 - $864,899
4,900 Added 25.75%
23,932 $3.81 Million
Q2 2023

Jul 27, 2023

BUY
$138.42 - $180.31 $279,885 - $364,586
2,022 Added 11.89%
19,032 $2.69 Million
Q1 2023

Apr 21, 2023

BUY
$154.26 - $198.1 $153,951 - $197,703
998 Added 6.23%
17,010 $2.86 Million
Q4 2022

Jan 18, 2023

BUY
$162.42 - $220.56 $427,814 - $580,955
2,634 Added 19.69%
16,012 $0
Q3 2022

Nov 08, 2022

SELL
$160.42 - $256.21 $998,774 - $1.6 Million
-6,226 Reduced 31.76%
13,378 $2.5 Million
Q2 2022

Aug 02, 2022

SELL
$140.68 - $188.02 $41 Million - $54.8 Million
-291,660 Reduced 93.7%
19,604 $3.18 Million
Q1 2022

Apr 20, 2022

BUY
$161.19 - $257.96 $11.6 Million - $18.6 Million
72,188 Added 30.19%
311,264 $58.5 Million
Q4 2021

Jan 28, 2022

SELL
$247.59 - $304.47 $19.7 Million - $24.3 Million
-79,655 Reduced 24.99%
239,076 $63.3 Million
Q3 2021

Nov 08, 2021

BUY
$194.77 - $324.21 $59.6 Million - $99.2 Million
305,838 Added 2372.12%
318,731 $92.1 Million
Q2 2021

Aug 05, 2021

SELL
$165.87 - $220.95 $7.28 Million - $9.7 Million
-43,916 Reduced 77.3%
12,893 $2.57 Million
Q1 2021

May 05, 2021

SELL
$180.37 - $226.26 $33,007 - $41,405
-183 Reduced 0.32%
56,809 $11 Million
Q4 2020

Jan 26, 2021

SELL
$148.08 - $206.57 $972,293 - $1.36 Million
-6,566 Reduced 10.33%
56,992 $10.9 Million
Q3 2020

Nov 03, 2020

SELL
$122.51 - $158.27 $213,902 - $276,339
-1,746 Reduced 2.67%
63,558 $9.38 Million
Q2 2020

Jul 23, 2020

SELL
$94.33 - $140.48 $740,396 - $1.1 Million
-7,849 Reduced 10.73%
65,304 $8.07 Million
Q1 2020

Apr 21, 2020

SELL
$84.96 - $109.14 $235,933 - $303,081
-2,777 Reduced 3.66%
73,153 $7.06 Million
Q4 2019

Feb 10, 2020

SELL
$73.84 - $93.08 $83,291 - $104,994
-1,128 Reduced 1.46%
75,930 $7.02 Million
Q3 2019

Nov 01, 2019

SELL
$76.65 - $95.51 $115,741 - $144,220
-1,510 Reduced 1.92%
77,058 $5.91 Million
Q2 2019

Aug 07, 2019

SELL
$54.2 - $85.95 $21,842 - $34,637
-403 Reduced 0.51%
78,568 $6.75 Million
Q1 2019

May 08, 2019

BUY
$49.45 - $62.8 $780,271 - $990,921
15,779 Added 24.97%
78,971 $4.67 Million
Q4 2018

Jan 25, 2019

SELL
$48.26 - $68.88 $282,803 - $403,636
-5,860 Reduced 8.49%
63,192 $3.33 Million
Q3 2018

Oct 26, 2018

BUY
$46.8 - $58.97 $3.23 Million - $4.07 Million
69,052 New
69,052 $3.83 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.98B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Congress Asset Management CO Portfolio

Follow Congress Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.